Zobrazeno 1 - 10
of 22
pro vyhledávání: '"R Sonnemaker"'
Publikováno v:
Clinical Chemistry. 38:887-894
We examined calibration and accuracy, precision, sensitivity, specificity, and "hook" effects for recently revised automated choriogonadotropin (hCG) immunoassay systems (Baxter-Dade Stratus II, Abbott IMx intact hCG and total beta hCG) and compared
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 75:S140-S141
Publikováno v:
Clinical Nuclear Medicine. 16:221
Autor:
Stanton E. Shuler, H. A. Fuselier, Harold R. Neely, J. C. Winters, Lynn R. Witherspoon, R Sonnemaker
Publikováno v:
Clinical Nuclear Medicine. 16:221
Publikováno v:
Clinical Chemistry. 34:17-23
Chemical blockers used to displace thyronine analog from albumin in analog kits for assay of free thyroxin (FT4) or free triiodothyronine (FT3) may also displace thyroxin (T4) or triiodothyronine (T3) from thyroxin-binding globulin (TBG), resulting i
Publikováno v:
Clinical Chemistry. 34:9-16
Analog assays for free thyroxin (FT4) produce inaccurate results because the T4 analog is sequestered by albumin. Diagnostic Products Corp. (DPC) introduced the concept of chemically blocking analog-albumin binding in 1982. While DPC succeeded in eli
Autor:
D, Ornish, L W, Scherwitz, R S, Doody, D, Kesten, S M, McLanahan, S E, Brown, E, DePuey, R, Sonnemaker, C, Haynes, J, Lester, G K, McAllister, R J, Hall, J A, Burdine, A M, Gotto
Publikováno v:
JAMA. 249(1)
To evaluate the short-term effects of an intervention that consists of stress management training and dietary changes in patients with ischemic heart disease (IHD), we compared the cardiovascular status of 23 patients who received this intervention w
Publikováno v:
Clinical chemistry. 33(3)
Autor:
L R, Witherspoon, A S, el Shami, S E, Shuler, H, Neely, R, Sonnemaker, S S, Gilbert, K, Alyea
Publikováno v:
Clinical chemistry. 34(1)
Analog assays for free thyroxin (FT4) produce inaccurate results because the T4 analog is sequestered by albumin. Diagnostic Products Corp. (DPC) introduced the concept of chemically blocking analog-albumin binding in 1982. While DPC succeeded in eli
Autor:
L R, Witherspoon, A S, el Shami, S E, Shuler, H, Neely, R, Sonnemaker, S S, Gilbert, K, Alyea
Publikováno v:
Clinical chemistry. 34(1)
Chemical blockers used to displace thyronine analog from albumin in analog kits for assay of free thyroxin (FT4) or free triiodothyronine (FT3) may also displace thyroxin (T4) or triiodothyronine (T3) from thyroxin-binding globulin (TBG), resulting i